Partial deletion of chromosome 6 syndrome

Partial deletion of chromosome 6 syndrome (also referred to as 6q partial monosomy or partial monosomy 6q, depending on the specific segment deleted) encompasses a group of rare chromosomal disorders caused by the loss of a portion of chromosome 6. The clinical presentation varies considerably depending on the size and precise location of the deleted segment (short arm 6p or long arm 6q). Common features may include intellectual disability, developmental delay, growth retardation, distinctive craniofacial features (such as microcephaly, broad or flat nasal bridge, low-set ears, and micrognathia), and various congenital anomalies. Some patients may also present with cardiac defects, skeletal abnormalities, hypotonia, and eye or hearing abnormalities. Because the phenotype is highly variable and depends on which genes are lost within the deleted region, no single clinical picture defines all cases. Deletions involving the short arm (6p) may be associated with different features compared to those involving the long arm (6q). Larger deletions tend to produce more severe clinical manifestations. Diagnosis is typically confirmed through chromosomal analysis, including karyotyping, fluorescence in situ hybridization (FISH), or chromosomal microarray analysis (CMA), which can precisely define the breakpoints and size of the deletion. There is currently no cure or targeted therapy for partial deletion of chromosome 6 syndrome. Management is supportive and symptomatic, tailored to the individual's specific clinical needs. This may include early intervention programs, speech and occupational therapy, special education services, surgical correction of congenital anomalies (such as cardiac or skeletal defects), and regular monitoring by a multidisciplinary team including geneticists, cardiologists, neurologists, and other specialists as needed.

Common questions about Partial deletion of chromosome 6 syndrome